Psychedelic Therapy for Substance Use Disorders: Neurobiology, Evidence Base, Regulatory Considerations, and Unintended Consequences
Back to course
Video Transcription
Video Summary
Asset Caption
Please note: The slide deck from this presentation is unavailable for distribution.
Keywords
psychedelic therapy
substance use disorders
Dr. Steve Ross
NYU
LSD
psilocybin
cognitive dissonance
therapeutic agents
legal background
societal background
clinical trials
alcohol use disorder
neurobiological mechanisms
FDA oversight
psychedelic medicine
 
American Academy of Addiction Psychiatry
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.


 
400 Massasoit Avenue
Suite 108
East Providence, RI 02914
cmecpd@aaap.org



About
Advocacy
Membership
Fellowship
Education and Resources
Training Events

 
Powered By